Pulse Wave Amplitude Drops Index: A Biomarker of Cardiovascular Risk in Obstructive Sleep Apnea.

Details

Ressource 1Download: Solelhac.pdf (1350.98 [Ko])
State: Public
Version: Final published version
License: CC BY-NC-ND 4.0
Serval ID
serval:BIB_32B3DB687D34
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Pulse Wave Amplitude Drops Index: A Biomarker of Cardiovascular Risk in Obstructive Sleep Apnea.
Journal
American journal of respiratory and critical care medicine
Author(s)
Solelhac G., Sánchez-de-la-Torre M., Blanchard M., Berger M., Hirotsu C., Imler T., Sánchez-de-la-Torre A., Haba-Rubio J., Marchi N.A., Bayon V., Bailly S., Goupil F., Waeber A., Heiniger G., Pigeanne T., Gracia-Lavedan E., Zapater A., Abad J., Ordax E., Masdeu M.J., Cabriada-Nuño V., Egea C., Van Den Broecke S., Vollenweider P., Marques-Vidal P., Vaucher J., Bernardi G., Betta M., Siclari F., Barbé F., Gagnadoux F., Heinzer R.
ISSN
1535-4970 (Electronic)
ISSN-L
1073-449X
Publication state
Published
Issued date
15/06/2023
Peer-reviewed
Oui
Volume
207
Number
12
Pages
1620-1632
Language
english
Notes
Publication types: Journal Article
Publication Status: ppublish
Abstract
Rationale: It is currently unclear which patients with obstructive sleep apnea (OSA) are at increased cardiovascular risk. Objective: To investigate the value of pulse wave amplitude drops (PWADs), reflecting sympathetic activations and vasoreactivity, as a biomarker of cardiovascular risk in OSA. Methods: PWADs were derived from pulse oximetry-based photoplethysmography signals in three prospective cohorts: HypnoLaus (N = 1,941), the Pays-de-la-Loire Sleep Cohort (PLSC; N = 6,367), and "Impact of Sleep Apnea syndrome in the evolution of Acute Coronary syndrome. Effect of intervention with CPAP" (ISAACC) (N = 692). The PWAD index was the number of PWADs (>30%) per hour during sleep. All participants were divided into subgroups according to the presence or absence of OSA (defined as ⩾15 or more events per hour or <15/h, respectively, on the apnea-hypopnea index) and the median PWAD index. Primary outcome was the incidence of composite cardiovascular events. Measurements and Main Results: Using Cox models adjusted for cardiovascular risk factors (hazard ratio; HR [95% confidence interval]), patients with a low PWAD index and OSA had a higher incidence of cardiovascular events compared with the high-PWAD and OSA group and those without OSA in the HypnoLaus cohort (HR, 2.16 [1.07-4.34], P = 0.031; and 2.35 [1.12-4.93], P = 0.024) and in the PLSC (1.36 [1.13-1.63], P = 0.001; and 1.44 [1.06-1.94], P = 0.019), respectively. In the ISAACC cohort, the low-PWAD and OSA untreated group had a higher cardiovascular event recurrence rate than that of the no-OSA group (2.03 [1.08-3.81], P = 0.028). In the PLSC and HypnoLaus cohorts, every increase of 10 events per hour in the continuous PWAD index was negatively associated with incident cardiovascular events exclusively in patients with OSA (HR, 0.85 [0.73-0.99], P = 0.031; and HR, 0.91 [0.86-0.96], P < 0.001, respectively). This association was not significant in the no-OSA group and the ISAACC cohort. Conclusions: In patients with OSA, a low PWAD index reflecting poor autonomic and vascular reactivity was independently associated with a higher cardiovascular risk.
Keywords
Humans, Cardiovascular Diseases/etiology, Cardiovascular Diseases/complications, Prospective Studies, Risk Factors, Sleep Apnea, Obstructive/complications, Heart Disease Risk Factors, Biomarkers, PWAD, cardiovascular risk, pulse oximeter, pulse wave amplitude, sleep apnea
Pubmed
Web of science
Open Access
Yes
Create date
11/04/2023 10:10
Last modification date
25/01/2024 8:28
Usage data